Bristol-Myers Squibb Co.
BMY
NYSE
IPO1952
about BMY
Bristol-Myers Squibb Co. is a leading pharmaceutical company focused on developing innovative medicines for diseases such as cancer, immunology, and cardiovascular disorders, providing life-saving treatments to patients worldwide.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $43.82 | $43.82 | $43.21 | $89.21B | 21.38M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.64 | n/a | 7.21 | 14.45% | 10.70% | 5.71% |